VetMotl Microfluidic Sperm Sample Prep Technology Now Available for Equine Reproduction

VetMotl, Inc. is introducing the VetMotl® Sperm Separation Devices, its microfluidic sperm sample preparation technology for broad use across equine ART procedures, including AI and deep-horn AI, ICSI, and IVF. The device is designed to improve fertilization potential and support higher pregnancy rates by providing a consistent, high-quality sperm sample preparation for equine breeding programs.

Using a microfluidic design that mimics aspects of the natural environment of the female reproductive tract, the VetMotl device passively separates healthy, progressively motile sperm from the original semen sample. This passive system supports reliable sample preparation from fresh, cooled, and frozen semen while reducing handling steps.

VetMotl’s approach focuses on functional sperm separation and standardized sample preparation. By allowing sperm to actively migrate into the collection chamber, the device enriches the prepared sample with sperm that demonstrate progressive motility and intact structure—key features associated with higher fertilization potential.

This functional separation helps address a core challenge in equine reproduction: variability in sperm quality and its impact on downstream fertilization and embryo development. By improving the quality and consistency of the prepared sperm sample used for each procedure, veterinarians and breeders are better positioned to achieve predictable outcomes across ART workflows.

Unlike conventional sperm preparation methods that can subject samples to repeated centrifugation and mechanical stress, VetMotl’s microfluidic system enables sperm to move passively into a collection chamber with minimal manipulation. This separation-based workflow improves the starting point for fertilization while helping to reduce variability between procedures and across semen types.

The VetMotl veterinary technology is derived from the clinically validated ZyM.t® platform, widely used in human fertility clinics, and has been adapted specifically for use in equine reproductive practice. By translating a proven microfluidic separation approach from human medicine into the veterinary field, VetMotl aims to raise the approach from human medicine into the veterinary field.

“We’re focused on helping veterinarians and breeders achieve more consistent outcomes by improving the starting point of every reproductive procedure—the quality of the prepared sperm sample,” said Bill Sharp, CEO of VetMotl. “By standardizing sperm separation and sample preparation, we can help drive better fertilization and pregnancy outcomes across a wide range of equine reproductive applications.”

As the use of advanced reproductive technologies continues to grow in the equine industry, VetMotl’s evidence-based microfluidic separation platform offers a standardized method to support improved fertilization potential and overall reproductive efficiency.

About VetMotl, Inc.

VetMotl, Inc. is a Maryland-based medical device company specializing in assisted reproductive technologies for veterinary medicine, commercializing the VetMotl Sperm Separation Devices to enhance sperm quality and performance in equine and bovine reproductive procedures. For more information, visit www.vetmotl.com and www.linkedin.com/company/vetmotl-inc.

Stay in the know! Sign up for EquiManagement’s FREE weekly newsletters to get the latest equine research, disease alerts, and vet practice updates delivered straight to your inbox.